An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes

Summary

The purpose of this study is to demonstrate that epoetin alfa works better than placebo in improving anemia in patients with lower-risk myelodysplastic syndromes (MDS). The safety of epoetin alfa will also be evaluated.

Timeline

Start

2011-10

Primary completion

2015-01

Completion

2016-01

Drugs

Indications